Antiplatelet Medication Reversal Strategies in Operative Intracranial Hemorrhage: A Survey of Practicing Neurosurgeons

World Neurosurgery

Volumn 116, Issue , 2018, Pages e649-e654

  Foreman, Paul M ^a   Ilyas, Adeel ^a   Mooney, James ^a   Schmalz, Philip G R ^a   Walters, Beverly C ^a   Griessenauer, Christoph J ^b,c  

^a University of Alabama at Birmingham   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Antiplatelet; Antiplatelet reversal; Epidural hematoma; Intracerebral hemorrhage; Intracranial hemorrhage; Subdural hematoma

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE ANTAGONIST; ANTITHROMBOCYTIC AGENT; DESMOPRESSIN; UNCLASSIFIED DRUG; ARGIPRESSIN[1 DEAMINO];

ARTICLE; BRAIN HEMORRHAGE; DUAL ANTIPLATELET THERAPY; EPIDURAL HEMATOMA; HEALTH CARE SURVEY; HUMAN; LABORATORY TEST; NEUROSURGEON; NEUROSURGERY; NORTH AMERICA; ONLINE SYSTEM; SUBDURAL HEMATOMA; THROMBOCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEALTH SURVEY; MALE; PSYCHOLOGY; TIME FACTOR;

DEAMINO ARGININE VASOPRESSIN; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; NEUROSURGEONS; PLATELET AGGREGATION INHIBITORS; TIME FACTORS;

EID: 85047837416     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2018.05.064     Document Type: Article

References (25)

1. Ajani, U.A., Ford, E.S., Greenland, K.J., Giles, W.H., Mokdad, A.H., Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. Am J Prev Med 30 (2006), 74–77.
2. Frontera, J.A., Lewin, J.J. 3rd, Rabinstein, A.A., Aisiku, I.P., Alexandrov, A.W., Cook, A.M., et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care 24 (2016), 6–46.
3. Ivascu, F.A., Howells, G.A., Junn, F.S., Bair, H.A., Bendick, P.J., Janczyk, R.J., Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma 65 (2008), 785–788.
4. Roquer, J., Rodriguez Campello, A., Gomis, M., Ois, A., Puente, V., Munteis, E., Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol 252 (2005), 412–416.
5. Saloheimo, P., Ahonen, M., Juvela, S., Pyhtinen, J., Savolainen, E.R., Hillbom, M., Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 37 (2006), 129–133.
6. Wong, D.K., Lurie, F., Wong, L.L., The effects of clopidogrel on elderly traumatic brain injured patients. J Trauma 65 (2008), 1303–1308.
7. Fortuna, G.R., Mueller, E.W., James, L.E., Shutter, L.A., Butler, K.L., The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. Surgery 144 (2008), 598–603 [discussion: 605].
8. Sansing, L.H., Messe, S.R., Cucchiara, B.L., Cohen, S.N., Lyden, P.D., Kasner, S.E., et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology 72 (2009), 1397–1402.
9. Moussouttas, M., Malhotra, R., Fernandez, L., Maltenfort, M., Holowecki, M., Delgado, J., et al. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. Neurocrit Care 12 (2010), 24–29.
10. Gaist, D., Garcia Rodriguez, L.A., Hellfritzsch, M., Poulsen, F.R., Halle, B., Hallas, J., et al. Association of antithrombotic drug use with subdural hematoma risk. JAMA 317 (2017), 836–846.
11. Bakheet, M.F., Pearce, L.A., Hart, R.G., Effect of addition of clopidogrel to aspirin on subdural hematoma: meta-analysis of randomized clinical trials. Int J Stroke 10 (2015), 501–505.
12. Hoddinott, S.N., Bass, M.J., The Dillman total design survey method. Can Fam Physician 32 (1986), 2366–2368.
13. Li, X., Sun, Z., Zhao, W., Zhang, J., Chen, J., Li, Y., et al. Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage. J Neurosurg 118 (2013), 94–103.
14. Naidech, A.M., Liebling, S.M., Rosenberg, N.F., Lindholm, P.F., Bernstein, R.A., Batjer, H.H., et al. Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocrit Care 16 (2012), 82–87.
15. Baharoglu, M.I., Cordonnier, C., Al-Shahi Salman, R., de Gans, K., Koopman, M.M., Brand, A., et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 387 (2016), 2605–2613.
16. Washington, C.W., Schuerer, D.J., Grubb, R.L. Jr., Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy. J Trauma 71 (2011), 358–363.
17. Joseph, B., Pandit, V., Sadoun, M., Larkins, C.G., Kulvatunyou, N., Tang, A., et al. A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage. J Trauma Acute Care Surg 75 (2013), 990–994.
18. Mannucci, P.M., Remuzzi, G., Pusineri, F., Lombardi, R., Valsecchi, C., Mecca, G., et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308 (1983), 8–12.
19. Kim, J.H., Baek, C.H., Min, J.Y., Kim, J.S., Kim, S.B., Kim, H., Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures. Ann Hematol 94 (2015), 1457–1461.
20. Flordal, P.A., Sahlin, S., Use of desmopressin to prevent bleeding complications in patients treated with aspirin. Br J Surg 80 (1993), 723–724.
21. Reiter, R.A., Mayr, F., Blazicek, H., Galehr, E., Jilma-Stohlawetz, P., Domanovits, H., et al. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood 102 (2003), 4594–4599.
22. Leithauser, B., Zielske, D., Seyfert, U.T., Jung, F., Effects of desmopressin on platelet membrane glycoproteins and platelet aggregation in volunteers on clopidogrel. Clin Hemorheol Microcirc 39 (2008), 293–302.
23. Naidech, A.M., Maas, M.B., Levasseur-Franklin, K.E., Liotta, E.M., Guth, J.C., Berman, M., et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke 45 (2014), 2451–2453.
24. Kapapa, T., Rohrer, S., Struve, S., Petscher, M., Konig, R., Wirtz, C.R., et al. Desmopressin acetate in intracranial haemorrhage. Neurol Res Int, 2014, 2014, 298767.
25. Kim, D.Y., O'Leary, M., Nguyen, A., Kaji, A., Bricker, S., Neville, A., et al. The effect of platelet and desmopressin administration on early radiographic progression of traumatic intracranial hemorrhage. J Neurotrauma 32 (2015), 1815–1821.